Skip to main navigation Skip to search Skip to main content

Evaluation of the Metabolic Effects of Exenatide, Rosiglitazone, & Exenatide Plus Rosiglitazone in Subjects with Type 2 Diabetes Mellitus Treated with Metformin

Project: Research

Project Details

StatusFinished
Effective start/end date11/10/06 → 11/9/09

Funding

  • Lilly Research Laboratories: $26,452.00